mAbxience EN2025-02-10T15:30:15+01:00

BIOPHARMACEUTICAL DEVELOPMENT

Experts in biologics, specialized in biosimilars

We are a leading vertically integrated biopharmaceuticals company, committed to improving patient access to treatments worldwide. Our in-house, core R&D competencies set us apart in the development of biosimilars and innovator biologics.

CDMO PLATFORM

End-to-end solutions to meet any manufacturing need

Thanks to our independent CDMO platform, we provide integrated services, adapted to your requirements: from research batches to commercial batches, big or small. We have over a decade of experience in the development and commercialization of biopharmaceuticals.

JOIN US!

Do you want to work at mAbxience?

WHAT’S NEW?

Catch up with our latest developments

Navigating global shifts: key takeaways from the 2025 J.P. Morgan Healthcare Conference

Navigating global shifts: key takeaways from the 2025 J.P. Morgan Healthcare Conference

News|

The blueprint for successful CDMO partnerships

The blueprint for successful CDMO partnerships

News|

From lab to market: mAbxience’s approach to biopharmaceutical development

Go to Top